The DOI matches its Crossref record; 178 of the 179 references it cites were found in a registry or an index.
SOCS3, a Major Regulator of Infection and Inflammation
Open accessAbstract
In this review, we describe the role of suppressor of cytokine signaling-3 (SOCS3) in modulating the outcome of infections and autoimmune diseases as well as the underlying mechanisms. SOCS3 regulates cytokine or hormone signaling usually preventing, but in some cases aggravating, a variety of diseases. A main role of SOCS3 results from its binding to both the JAK kinase and the cytokine receptor, which results in the inhibition of STAT3 activation. Available data also indicate that SOCS3 can regulate signaling via other STATs than STAT3 and also controls cellular pathways unrelated to STAT activation. SOCS3 might either act directly by hampering JAK activation or by mediating the ubiquitination and subsequent proteasome degradation of the cytokine/growth factor/hormone receptor. Inflammation and infection stimulate SOCS3 expression in different myeloid and lymphoid cell populations as well as in diverse non-hematopoietic cells. The accumulated data suggest a relevant program coordinated by SOCS3 in different cell populations, devoted to the control of immune homeostasis in physiological and pathological conditions such as infection and autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC5 promotes the upregulation of Chemokine ligand 2 (CCL2) by inhibiting SOCS3, thereby recruiting CCR2+ macrophages [147].”
From Targeting KRAS mutant cancers: from druggable therapy to drug resistance (2022) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization
Spence, S., Fitzsimons, A., Boyd, C. R., Kessler, J., Fitzgerald, D. C., Elliott, J., Gabhann, J. N., Smith, S., Sica, A., Hams, E., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.013 · Cited by 96
RetractedYaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“Binding to the cytokine activates the kinase function of JAK, a tyrosine kinase that binds to the receptor, which auto-phosphorylates itself, cross-phosphorylates a JAK molecule bound to the accompanying heterodimer chain of the cytokine receptor and also different tyrosine sites on the cytokine receptor (1).”
BackgroundNotch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Colman (2022) · doi:10.1073/pnas · Cited by 4,370
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 4×
“SOCS3 has been also suggested to inhibit IL-12-induced STAT4 activation by direct binding to IL-12Rβ2 (37), the IL-12R subunit that is not shared with the IL-23R.”
BackgroundInfluentialJournal of Biological Chemistry
Kurkinensp, M., CondongT, M. R., Blumberg, B., Barlow, D. P., Quiñones, S., Sausg, J., & Pihlajaniemisyy, T. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,427
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Cited by
Sorted by citations
Items 501–566 of 566
Castleman Disease Versus Generalized Tuberculosis: A Case of Fever of Unknown Origin
Morin, E. N., Morillos, D. S., & Barreda-Celis, R. (2023) · International Journal of Medical Case Reports · doi:10.11648/j.ijmcr.20230203.12
Galyamina, A. G., Kovalenko, I. L., Смагин, Д. А., & Попова, Н. А. (2024) · Medical Immunology (Russia) · doi:10.15789/1563-0625-cit-16769
Gioiosa, S., Gasparini, S., Presutti, C., Rinaldi, A., Castrignanò, T., & Mannironi, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4895075/v1
Shi, J., Xu, A., Huang, L., Liu, S., Wu, B., & Zhang, Z. (2024) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s488143
“37 SOCS3 plays a role in inhibiting the M1 proinflammatory state, thus reducing the activity of inflammatory reactions within macrophages.”
Pan, Y., Zhang, Y., Sooranna, S. R., Yang, X., Zhou, Y., Chen, L., Xu, F., & Huang, D. (2025) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073335295241216152011
Neysi, S., Fayazi, J., Roshanfekr, H., & Imumorin, I. G. (2025) · Animals · doi:10.3390/ani15101472
“Furthermore, 43 circRNAs interacted with miR-181a, regulating immune and inflammatory mediators such as TLR4, SRGN, SOCS3, and CXCL3 [30–32].”
Peters, L. D., Seay, H. R., Smith, J., Posgai, A. L., Berkowitz, R. L., Wasserfall, C. H., Atkinson, M. A., Bacher, R. L., Brusko, M., & Brusko, T. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.23.655848
Buscher, K., Temprine, K., Mays, C., Aabed, N., Kerk, S. A., Bell, H. N., Carrion, J. A. N., Greenbaum, H. S., Ponnusamy, V., Ramakrishnan, S. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.22.666143
“These results suggest that glucose-mediated STAT3 activation occurs independently of transcriptional regulation of canonical upstream components or negative feedback regulators, such as SOCS3 9,10 .”
InfluentialHakimi, P., Alborzi, M., Zakariya, N. A., Pouya, K., Rezazadeh, M., & Ghafouri‐Fard, S. (2025) · Middle East Fertility Society Journal · doi:10.1186/s43043-025-00247-4
“Moreover, the protein known as suppressor of cytokine signaling 3 (SOCS3) plays a crucial role in the regulation of cytokine signaling [60].”
Spinal Cord Injury Imprints a Glucocorticoid-Driven Failure State in Hematopoietic Stem CellsPreprint
Rodgers, K. A., Garfinkle, E. A. R., Kigerl, K. A., Adib, E. A., Mifflin, K. A., Hall, J. C. E., Kulkarni, R. S., Wang, C., Goda, C., Dias, A. C. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.05.680535
The Role of Sex Hormones and Gender Differences in the Immunity of Cancer
Cosci, I., Fiore, P. D., D, S. M. M., & Ferlin, A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_377
Wu, L.-H., Kuo, Y., Lin, F., Fitriana, I., Yang, C., Shen, Y.-C., Liu, Y., Jiang, C., Yen, J.-L., Lee, Y., et al. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110762
Alipeddi, R. R., Padala, C., Puranam, K., Ulaganathan, K., Neeharika, R. D., Sampanmudumby, P., Chinta, S., & Hanumanth, S. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02284-4
“SOCS3 is one of the SOCS protein family and has numerous gene polymorphisms at different loci, located on the chromosome region 17q24-17q25 [11].”
Alipeddi, R. R., Rani, D. N., Sampanmudumby, P., & Hanumanth, S. R. (2025) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2025.111925
Qiu, W., Wu, Q., Zhang, K., Da, X., Tang, K., Yuan, N., Deng, L., Wu, M., Zhang, Y., Quan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22621324
Du, X., Peñalva, R. G., Little, K., Kissenpfennig, A., Chen, M., & Xu, H. (2021) · Figshare · doi:10.6084/m9.figshare.14059735
Du, X., Peñalva, R. G., Little, K., Kissenpfennig, A., Chen, M., & Xu, H. (2021) · Figshare · doi:10.6084/m9.figshare.14059744
Du, X., Peñalva, R. G., Little, K., Kissenpfennig, A., Chen, M., & Xu, H. (2021) · Figshare · doi:10.6084/m9.figshare.14059741
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660663
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660666
Du, X., Peñalva, R. G., Little, K., Kissenpfennig, A., Chen, M., & Xu, H. (2021) · Figshare · doi:10.6084/m9.figshare.14059747
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660693
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660681
Slot, E., Boers, R., Boers, J., van IJcken, W. F. J., Tibboel, D., Gribnau, J. H., Rottier, R. J., & de Klein, A. (2021) · Figshare · doi:10.6084/m9.figshare.15080324
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660690
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660684
Du, X., Peñalva, R. G., Little, K., Kissenpfennig, A., Chen, M., & Xu, H. (2021) · Figshare · doi:10.6084/m9.figshare.14059738
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660672
Selvan, G. T., Gollapalli, P., Shetty, P., & Kumari, N. S. (2022) · Figshare · doi:10.6084/m9.figshare.20003786
Slot, E., Boers, R., Boers, J., van IJcken, W. F. J., Tibboel, D., Gribnau, J. H., Rottier, R. J., & de Klein, A. (2021) · Figshare · doi:10.6084/m9.figshare.15080330
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660678
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660669
Slot, E., Boers, R., Boers, J., van IJcken, W. F. J., Tibboel, D., Gribnau, J. H., Rottier, R. J., & de Klein, A. (2021) · Figshare · doi:10.6084/m9.figshare.15080337
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660675
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660687
Du, X., Peñalva, R. G., Little, K., Kissenpfennig, A., Chen, M., & Xu, H. (2021) · Figshare · doi:10.6084/m9.figshare.14059750
Olney, K. C., de Ávila, C., Todd, K. T., Tallant, L. E., Barnett, J. H., Gibson, K. A., Hota, P., Pandian, A. S., Durgun, P. C., Serhan, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26660696
Zhang, L., Zhu, Y., Fang, Y., Yang, Y., Yu, Y., Wang, H., Jiang, X., Zhang, X., & Huang, D. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2025.1753636
“We speculated PTPN2 and SOCS3 inhibit the JAK2-STAT3 activities (Zhang et al., 2018; Carow and Rottenberg, 2014).”
Kodama-Maruyama, Y., Tsurushima, H., Koga, A., Nagai‐Yoshioka, Y., Yamasaki, R., Habu, M., Yoshioka, I., & Ariyoshi, W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031157
“However, there is also a negative feedback mechanism in the inflammatory response where SOCS3, induced by the JAK/STAT pathway, suppresses JAK [40] and TLR4 signaling [41].”
Zinc suppresses Stat3-driven IL-6 production in primary mouse adipocytes
Chung, H., Eom, J., Damen, M. S. M. A., Stankiewicz, T. E., Sawada, K., Alarcon, P. C., Ulanowicz, C. J., Wayland, J. L., Deepe, G. S., & Divanovic, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1714168
“As with Dusp5 and Erk signaling, Socs3 is a suppressor of Stat signaling pathway whose expression is induced by active Stat3, forming a negative feedback loop that controls cytokine production (50).”
Wei, Z., Wang, P., Jiang, W., Man, J., Huang, Y., Wang, X. C., Wang, H., Qian, X., & Zhai, X. (2026) · Transplant Infectious Disease · doi:10.1111/tid.70155
Bugs as drugs: parasite biomolecules as novel therapeutics against breast cancer
Gonzalez, S. B., Shivam, P., Ball, D., Ajisegiri, S. B., Osi, I., Misra, S., Mutchler, A. P., Lindsey, M. L., Martin, P. M., Sakwe, A. M., et al. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00870.2025
Knockdown of SOX4 attenuates sepsis myocardial injury by inhibiting the EZH2/H3K27me3/SOCS3 axis
Zhao, H., Tao, W., Huang, R., Cao, J., & Xu, C. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10206-7
Investigation of intramacrophage stages of Burkholderia cenocepacia using a zebrafish model
Zhang, L. (2016) · theses.fr (ABES) · doi:10.70675/d35cf780z490cz4423z8050zdd2f4021d139
Rôle de l'oncostatine M et des interleukines 6 et 31 dans l'inflammation cutanée chez la souris
Pohin, M. (2017) · theses.fr (ABES) · doi:10.70675/6ee5de11z33c0z4d68z9887z2c7a7194291a
“Ce dernier est décrit pour se fixer à la sous-unité gp130 et inhiber la phosphorylation des protéines JAK associées au récepteur des cytokines de la fa ille de l IL-6 (Carow and Rottenberg 2014).”
BackgroundDeciphering the Interlink between STAT3 and MAPKs in Ischemia/Reperfusion and Ischemic Conditioning
Harhous, Z. (2019) · theses.fr (ABES) · doi:10.70675/20048ff2zb169z42acz8aefzad821856b904
Tarrass, M. A. (2023) · theses.fr (ABES) · doi:10.70675/aea61e27z0cadz4558za7acz92d960d99b81
Li, K., Long, D., Wang, L., Hao, R., Man, Y., & Ma, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1786276
IL-6-JAK2-STAT3 Signaling Pathway and the Pathogenesis of Chronic Tonsillitis
Li, S. X., Li, X., Lu, J., Yang, H., Yang, H., & Zhang, H. (2026) · Journal of Interferon & Cytokine Research · doi:10.1177/10799907261442845
“Additionally, SOCS3 inhibits STAT3 activation and modulates other signaling pathways such as NF-j B and cAMP (Carow and Rottenberg, 2014).”
Nwofor, O. V., Leipold, A. M., Chen, Q., Geffers, R., Saliba, A., Goldmann, O., & Medina, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1776887 · Cited by 2
“In this regard, the genes encoding the Suppressor of Cytokine Signaling 1 (SOCS1) and 3 (SOCS3), which are potent negative regulators of both type I and type II interferon signaling pathways (51, 52), were signi fi cantly upregulated in the liver of infected mice at 24 h of infection.”
Fang, W., Huang, R., Wu, Z., Tong, W., Hu, M., Li, Y., & Zheng, S. (2026) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2026.111483
(40767), Y. Z., Li, Q., Xu, S., Luo, Y., Liu, W., & Liu, Y. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112666
Monney, B., Ewaoluwagbemiga, E. O., & Kasper, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.26.733976
“In particular, candidate genes such as SDS , SHMT2 , SAA3 , SOCS3 , IGF2 , and CD36 could be examined in new cohorts under protein-restricted condi-787 tions, either through targeted assays such as qPCR or within additional RNA-seq datasets gener-788 ated from related experiments addressing complementary questions.”
InfluentialShen, Q., Zou, H., Jin, L., Liu, J., Wang, S., Li, N., Zhou, R., Yue, M., Wang, B., Yang, R., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.06.021
Liu, G., Xian, H., Xu, Y., Ma, J., Huang, J., & Ye, L. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1844856
Yao, J., Liu, Z., Zhang, J., Long, X., Chen, C. F., & Yuan, L. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-026-03133-9
Wang, J., Hou, G., Song, Z., Gao, K., Wang, H., & Li, T. (2026) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70041
“17,20 In gliomas, reduced SOCS3 expression may lead to persistent STAT3 activation, thereby enhancing GSCs' survival and proliferative capabilities.”
Xiao, D., Long, S., & Yang, P. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101547
Li, N.-C., Xin, M.-L., Song, X., Wang, H.-Y., Yang, F.-Y., Li, J.-D., & Sun, W.-L. (2026) · Food & medicine homology. · doi:10.26599/fmh.2027.9420159
Chang, S.-H., Hung, K. H., Tsai, H.-F., Ma, C., Hu, K., & Yeh, L. (2026) · Bioinformatics and Biology Insights · doi:10.1177/11779322261489962
“41 Although direct mechanistic confirmation in corneal tissue remains limited, these components collectively suggest a coordinated inflammatory signaling environment associated with disease activity.”
Zhang, Y., Liu, P., Peng, Y., Chen, Y., Lei, E., & Liu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1963905
Metadata
- Authors
- Carow, B., & Rottenberg, M. E.
- Affiliations
- Karolinska Institutet (SE)
- Corresponding author
- Carow, Berit
- ORCID
- Carow, Berit
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014
- Volume
- 5
- Pages
- 58-58
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC3928676
- OpenAlex
- W2140013858
- Cited by
- 555
- References
- 179
- Citations by year
- 2026: 31 · 2025: 55 · 2024: 65 · 2023: 71 · 2022: 64 · 2021: 58 · 2020: 43 · 2019: 52 · 2018: 31 · 2017: 25 · 2016: 27 · 2015: 24 · 2014: 9
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- SOCS3, suppressor of cytokine signaling, infection, inflammation, autoimmune disease, STAT3 activation, JAK kinases, cytokine signaling, receptor ubiquitination, proteasomal degradation, immune homeostasis, myeloid cells, lymphoid cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review